Meridian Diagnostics is an international medical diagnostics company that offers products and services to healthcare providers, laboratories, and employers. The company is also a leader in biopharmaceutical enabling technologies. It provides testing platforms and reagents for the diagnosis of a variety of diseases.
Meridian is a fully integrated life science company that has operations in more than 60 countries. It sells products through independent distributors and through its direct sales force. For instance, its ImmunoCard brand of rapid immunoassays has been approved by the Food and Drug Administration (FDA) for the diagnosis of Clostridium difficile.
In 2004 Meridian received ISO 13485 certification, a sign that the company’s processes are certified to meet the highest standards of health care. The company offers real-time PCR amplification under its Revogene brand and has developed anodic strip voltammetry under the LeadCare brand.
Meridian Bioscience is based in Cincinnati, Ohio. Founded in 1976, it manufactures and sells diagnostic test kits and bioresearch reagents. Products are sold through a network of independent distributors and physicians’ offices. Additionally, the company’s laboratory provides testing and interpretation of reports.
Aside from its headquarters in Cincinnati, Ohio, Meridian has manufacturing operations in Modi’in, Israel, and Quebec City, Canada. The company’s products are sold in over 60 countries around the world and are used by hospitals, laboratories, and medical clinics.
Meridian has been recognized as one of the Best 200 Small Companies in the US for five consecutive years. Its products are shipped in millions of units all over the world, and it is a leading supplier of laboratory and clinical diagnostics.
Meridian Diagnostics has a talented and resourceful staff that ensures timely and effective services. Their technicians are ASCP-certified and focus on hematology, chemistry, immunoassay, and COVID-19 testing. They also provide respiratory pathogen panels and blood panel analyses.
Meridian Diagnostics’ products are offered through seven international offices. They also offer services to substance abuse clinics, mental health facilities, and rehabilitation programs. The team is always willing to help patients interpret their reports. The lab keeps up with the latest advances in disease treatment.
Meridian has an annual production of more than 1.5 million units. The company’s products are shipped to more than 60 countries, and its test kits have been certified by the National Institutes of Health.
The company has a market capitalization of about $1 billion. On January 27, 2019, Meridian Therapeutics was granted FDA marketing clearance. As a result, the company is now a full-fledged member of the biopharmaceutical industry.
Meridian is currently traded on the NASDAQ Stock Exchange. The company is expected to close the acquisition of its parent company in the fourth calendar quarter of 2022. However, the transaction is subject to regulatory approvals and custom closing conditions.
The purchase will leave the Meridian leadership in place. This includes executive chairman William J. Motto, who had a hand in the company’s start. He reportedly started the business with only $500 in his basement. Eventually, he made the company public.
Contact us on